Researchers
Patient-Powered Biospecimens and Data
Procure Human Biospecimens Prospectively
Having confidence in your results requires access to clinically relevant biospecimen types and comprehensive datasets to make accurate conclusions. But sample criteria are increasingly specific, patient populations are harder and harder to reach, and study designs can seem impossible.
By leveraging an engaging direct-to-patient approach coupled with on-demand specimen procurement and data collection capabilities, you’ll touch even the hardest to reach populations. Our fully integrated service solution is simple and has you covered from start to finish—including same-day delivery.
1
Recruitment
& Screening
2
Informed Consent
3
@Home Sample
& Data Collection
4
Delivery
1
Recruitment
& Screening
2
Informed Consent
3
@Home Sample
& Data Collection
4
Delivery
Human Biospecimen Types
Our specimen procurement capabilities are minimally invasive and are further supported by in-home centrifugation, supplementary laboratory services (e.g., isolation of peripheral blood mononuclear cells (PBMCs), HLA typing, comprehensive clinical testing), and temperature-sensitive shipments according to your study protocol.
Blood-Derived Biofluids and Products
Non-Blood-Derived Biofluids
- Nasal mucosa
- Non-induced sputum
- Saliva
- Semen
- Stool
- Urine
Why Sanguine
A custom-tailored approach means an enhanced ability to recruit participants and procure biospecimens prospectively. You’ll get more accurate data points per sample, increased study design flexibility, and an expedited time to completion.
Same-day specimen procurement and delivery
Nationwide patient member community to meet complex inclusion/exclusion criteria
Medical record-verified eligibility and pre-screening
Access to electronic medical records, health histories, patient-reported datasets
Long-term follow-up with study participants
We Specialize in These Conditions
Behind our therapeutic experience are patient member communities made up of more than 50,000 total members ready to advance science and medicine for the conditions they live with.
Get Samples for My Research
Compliance & Quality Assured
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.
Sanguine utilizes two commercial, internationally-recognized IRBs for review and approval of all study protocols, specific study documentation, and study participant facing information.
Advarra is organized and operates in compliance with the US and international regulations and policies governing research with human subjects, as applicable. These include but are not limited to: US federal regulations at 21 CFR parts 50, 56, 312, and 812; US federal regulations at 45 CFR part 46; Part C, Division 5 of the Canadian Food and Drug Regulations; the Canadian Tri-Council Policy Statement 2; and the International Conference on Harmonisation (ICH) E6, Good Clinical Practice (GCP). Advarra may rely upon federal or international guidance to inform its policy development and approaches. Advarra’s IRB is registered with FDA and OHRP. Advarra’s Federalwide Assurance (FWA) has been approved by OHRP; IRB Organization (IORG) Number is 0000635, FWA Number is 00023875 and IRB Registration Number is 00000971. Please note that the IRB registration number applies for both FDA and OHRP registrations and covers all general, therapeutically focused, and country-specific panels. Advarra is fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
WCG IRB is duly constituted, has written procedures for initial and continuing review of clinical trials; prepares written minutes of convened meetings, and retains records pertaining to the review and approval process; all in compliance with requirements of FDA regulations 21 CFR Parts 50 and 56, HHS regulations 45 CFR 46, and International Conference on Harmonization (ICH) E6, Good Clinical Practice (GCP), as applicable. WCG IRB is registered with OHRP/FDA; IRB registration number is IRB00000533, parent organization number is IORG0000432 (WCG IRB Canada registration number is IRB00002354). WCG IRB also reviews in compliance with other applicable federal and state laws and regulations governing IRBs and research with human beings. Where appropriate, WCG IRB complies with additional regulations and guidelines (such as the Canadian Tri-Council Policy Statement, Ethical Conduct for Research Involving Humans) as required in specific research jurisdictions. WCG IRB continues to be fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).